Getein Biotech (SHSE:603387) Total Liabilities : ¥964 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Getein Biotech Total Liabilities?

Getein Biotech's Total Liabilities for the quarter that ended in Mar. 2024 was ¥964 Mil.

Getein Biotech's quarterly Total Liabilities declined from Sep. 2023 (¥1,088.46 Mil) to Dec. 2023 (¥1,030.38 Mil) and declined from Dec. 2023 (¥1,030.38 Mil) to Mar. 2024 (¥963.62 Mil).

Getein Biotech's annual Total Liabilities increased from Dec. 2021 (¥863.90 Mil) to Dec. 2022 (¥1,014.29 Mil) and increased from Dec. 2022 (¥1,014.29 Mil) to Dec. 2023 (¥1,030.38 Mil).

Getein Biotech Total Liabilities Historical Data

The historical data trend for Getein Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getein Biotech Total Liabilities Chart

Getein Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

325.98

700.11

863.90

1,014.29

1,030.38

Getein Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															892.26	1,011.04	1,088.46	1,030.38	963.62

Getein Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Getein Biotech's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	977.857	+	(2.713	+	49.81
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,030

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3771.626	-	2741.246
	=	1,030

Getein Biotech's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	911.891	+	(3.823	+	47.904
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	964

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	3788.151	-	2824.534
	=	964

Getein Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Getein Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Getein Biotech (SHSE:603387) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getein Biotech Inc (SHSE:603387) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505

Website

http://www.bio-gp.com.cn

Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.

Executives

Su En Kui	Director
Yan Bin	Director
Kong Ting Ting	Director
Xu Xing De	Director
Su En Ben	Director

Getein Biotech (SHSE:603387) Headlines

No Headlines